Tuesday, May 27, 2014

Best Companies To Own For 2015

What gives JPMorgan Chase (NYSE: JPM  ) its premium valuation? According to one analyst, it's having a CEO who certifies flawed internal controls processes and otherwise obscures risk so shareholders think their investment is safer than it actually is.

That's right... according to Charles Peabody, an analyst at Portales Partners, "shareholders may just find that [JPMorgan's stock] loses its premium valuation" if Jamie Dimon leaves the company. Peabody elaborates, "If that were to occur, is there someone with Mr. Dimon's talents capable of stepping into the breach?"

Here's why I think that's a bunch of baloney.

Dimon's "talents"
Given Dimon's recent track record of ticking off regulators, misleading shareholders, and taking on excessive risk, I don't believe his particular set of "talents" hold so much appeal. Here are just a few of his most egregious recent sins:

After certifying the adequacy of JPMorgan's internal controls in May of 2012, the company had to restate its financials and report material weaknesses in its internal controls in June. Dimon obscured risk from shareholders by dismissing investor concerns about the London Whale trades by calling the threat a "tempest in a teapot" even though he was allegedly aware of the size and complexity of the bet and the losses already incurred from it. The company took on excessive risk under Dimon through the London Whale trades and chose to deal with risk limit breaches by ignoring them and by altering risk models to obscure the risk. An investigation by the U.S. Senate found that Dimon withheld profit and loss data from federal regulators. One employee of the Office of the Comptroller of the Currency (OCC) recalled that the bank would regularly challenge findings and recommendations, and that bank executives would even yell at OCC examiners and call them "stupid."

Premium valuation
In the face of Dimon's missteps, I suspect much of JPMorgan's premium valuation has resulted from some of the achievements reported in its 2013 preliminary proxy, including:

Best Companies To Own For 2015: CYS Investments Inc (CYS)

CYS Investments, Inc. is a specialty finance company created with the objective of achieving consistent risk-adjusted investment income. The Company invests in Agency residential mortgage-backed securities (RMBS) collateralized by fixed rate single-family residential mortgage loans (typically 15, 20 or 30 years), adjustable-rate mortgage loans (ARMs), which typically have coupon rates that reset monthly, or hybrid ARMs, which typically have a coupon rate that is fixed for an initial period (typically three, five, seven or 10 years) and thereafter resets at regular intervals. In addition, its investment guidelines permit investments in collateralized mortgage obligations issued by a government agency or government-sponsored entity that are collateralized by Agency RMBS (CMOs), although the Company had not invested in any CMOs as of December 31, 2011.

The Company finances its Agency RMBS investments using a diversified approach involving repurchase agreements with multiple commercial and investment banks. Agency RMBS are residential mortgage pass-through securities, the principal and interest of which are guaranteed by the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation (Freddie Mac) or the Government National Mortgage Association (Ginnie Mae). Its portfolio of Agency RMBS is backed by fixed rate mortgages and hybrid ARMs that typically have a fixed coupon for three, five or seven years, and then pay an adjustable coupon that generally resets annually over a predetermined interest rate index. As of December 31, 2011, its Agency RMBS portfolio consisted of 10 Year Fixed Rate, 15 Year Fixed Rate, 20 Year Fixed Rate, 30 Year Fixed Rate and Hybrid ARMs. On September 1, 2011, the Company acquired certain assets and entered into agreements to internalize its management (the Internalization).

Advisors' Opinion:
  • [By Eric Volkman]

    CYS Investments (NYSE: CYS  ) is being a little more generous this quarter with its common stock payout. The company has declared a quarterly dividend of $0.34 per share for that class of security, to be paid on July 17 to shareholders of record as of June 25. That amount is $0.02 higher than the firm's previous common stock distribution, which was paid in April.

Best Companies To Own For 2015: Stemline Therapeutics Inc (STML)

Stemline Therapeutics, Inc. (Stemline), incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target both cancer stem cells (CSCs) and tumor bulk. The Company is developing two clinical-stage product candidates, SL-401 and SL-701, for which it holds global marketing rights. The indication for SL-401, a biologic-drug conjugate, is acute myeloid leukemia (AML). The indications for SL-701, a synthetic peptide vaccine, are pediatric and adult brain cancer. It has a platform, StemScreen, for the discovery of CSC-targeted compounds, from which it has discovered or validated several of its clinical and preclinical product candidates. Stemline�� StemScreen consists of StemScreen-1 and StemScreen-2 for the identification of CSC-directed compounds.

SL-301 is a small molecule gamma-secretase inhibitor that inhibits Notch, a pathway expressed by CSCs and tumor bulk of multiple cancer types. SL-101 is a monoclonal antibody-based (mAb -based) compound that targets CD123 and has shown in vitro activity against certain hematologic cancers. SL-201 is a small molecule active against certain hematologic and solid tumor types. SL-601 is a mAb-based compound that targets a cell surface marker on bladder CSCs, which is also expressed on a variety of other solid tumor types. It has also in-licensed certain intellectual property directed to mAb-based therapeutics to validated oncology targets, including Glypican-3, Tie-1, CD133, Frizzled, Smoothened and Patched.

SL-401 - An IL-3R-Directed Compound Targeting Cancer Stem Cells and Tumor Bulk

SL-401 is a clinically active biologic-drug conjugate consisting of human interleukin-3 (IL-3) genetically linked to a truncated version of diphtheria toxin. SL-401 targets the IL-3 receptor (IL-3R), which is overexpressed on both the CSCs and tumor bulk of multiple hematologic cancers, including AML. SL-401 has demonstrated preclinical in vit! ro and in vivo activity against both leukemia blasts (which includes tumor bulk) and CSCs of a range of human leukemia cell lines and primary leukemia cells from patients.

SL-701

SL-701 is a clinically active synthetic peptide vaccine that targets several epitopes on CSCs and tumor bulk of brain cancer. In two completed Phase 1/2 clinical trials, SL-701 demonstrated single agent anti-tumor activity in pediatric patients with newly diagnosed brainstem glioma (BSG) and other high-grade gliomas (HGGs) and in adult patients with refractory or recurrent GBM, and other HGGs.

StemScreen-1

StemScreen-1 is a drug discovery platform designed to identify CSC-targeted compounds based on the isolation of CSCs and evaluation of CSC gene expression profiles. CSCs are isolated from primary tumor tissue or cell lines, and then subjected to gene expression analysis using a variety of technologies, including microarray. A control tissue, such as normal bone marrow is analyzed as a comparator against the gene expression profile of the isolated CSCs. These data are then interfaced with an information base of compounds and their mechanisms of action (that is which gene products and pathways they impact). It has utilized StemScreen-1 to discover a number of its preclinical drug candidates. These include SL-201, SL-301, and SL-601. In addition, SL-401 demonstrated activity against CSCs as determined by both an in vitro colony formation and in vivo animal implantation assay, thereby validating certain StemScreen-1 anti-CSC assays.

StemScreen-2

StemScreen-2 is a high throughput drug discovery platform it is developing to discover anti-CSC compounds. StemScreen-2 utilizes a cell-based assay that can track and follow CSCs in their natural state during high throughput screening. In particular, StemScreen-2 utilizes a CSC-specific promoter linked to a reporter as a method for identifying and following CSCs in their native environment of surrounding tumor b! ulk. In t! his way, StemScreen-2 enables the identification of compound hits, in a high throughput manner, with anti-CSC activity.

The Company competes with Boston Biomedical, Inc., Eclipse Therapeutics, Inc., OncoMed Pharmaceuticals, Inc., Verastem, Inc., Astellas Pharma US, Inc., Boehringer Ingelheim GmbH, Dainippon Sumitomo Pharma Co. Ltd., Geron Corp., GlaxoSmithKline plc, ImmunoCellular Therapeutics, Ltd, Macrogenics Inc., Amgen, Inc., Pfizer Inc., Roche Holding AG, Sanofi U.S. LLC., Cyclacel Pharmaceuticals, Inc., Sunesis Pharmaceuticals Inc., Clavis Pharma ASA, Ambit Biosciences Corporation, Celgene Corporation, Eisai Co. Ltd., Celator Pharmaceuticals, Inc., Merck & Co., Inc., Eisai Co., Inc., Roche Holding AG, Novartis AG and Celldex Therapeutics, Inc.

Advisors' Opinion:
  • [By Keith Speights]

    Best-performing biotech IPO
    Stemline Therapeutics� (NASDAQ: STML  ) has only traded publicly this year, but what a year it's been. The stock's performance ranks Stemline as the best-performing biotech IPO so far in 2013. This week has been pretty good also, with shares moving up by 28%.

  • [By David Zeiler]

    3. Stemline Therapeutics Inc. (Nasdaq: STML): This biotech develops drugs that target cancer stem cells and tumors. Stemline went public January 29 at $10 a share and rose just 11.78% on its first day. But STML has climbed steadily since, and currently trades at $37.46, up 274.6% from its IPO price.

5 Best Recreation Stocks To Buy For 2015: Anglo American PLC (AAUKY.PK)

Anglo American plc (Anglo American), incorporated on May 14, 1998, is a mining company. The Company�� portfolio include Bulk commodities which consists of iron and manganese, metallurgical coal and thermal; base metals, which consists of copper, nickel and niobium; Precious metals and minerals, which include platinum and diamonds and Other Mining and Industrial. The Company operates in Africa, Brazil, Chile, North and South America, Australia, China, India, Japan, other Asia and Europe. In November 2013, Anglo American PLC announced the completion of its sale of the Amapa iron ore operation in Brazil (Amapa) to Zamin Ferrous Ltd. In January 2014, Anglo American completed the acquisition of Mineral Technology Exploration Production SA (MINTEP) and Societe Miniere d'Alumine SA.

Iron and Manganese

The Company�� Iron Ore portfolio consist a 69.7% holding in Kumba Iron Ore Limited (Kumba), a supplier of seaborne iron ore, and Iron Ore Brazil�� 100% interest in Anglo Ferrous Minas-Rio, a 49% shareholding in LLX Minas-Rio, which owns the port of Acu, and a 70% interest in the Amapa iron ore system. During the year ended December 31, 2012, Kumba operated three mines: Sishen Mine in the Northern Cape, which produced 33.7 million tons (MT) of iron ore, Thabazimbi Mine in Limpopo, with an output of 0.8 MT and Kolomela mine, also in the Northern Cape and produced 1.5 MT. During 2011, Kumba exported more than 85% of its total iron ore sales volumes of 44.4 million tons, with 69% of these exports destined for the People�� Republic of China and the remainder to Europe, Japan, South Korea and the Middle East. Its Minas-Rio iron ore project is located in the states of Minas Gerais and Rio de Janeiro.

The Company�� Manganese interests consist of a 40% holding in Samancor Holdings, which owns Hotazel Manganese Mines and Metalloys, both in South Africa, and a 40% holding in each of the Australian-based operations Groote Eylandt Mining Company (GEMCO) and Tasmanian Electro ! Metallurgical Company (TEMCO), with BHP Billiton owning 60% and having management control. It is producer of seaborne manganese ore and is top three global producers of manganese alloy. Its operations produce a combination of ores, alloys and metal from sites in South Africa and Australia.

Metallurgical Coal

The Company�� coal operations in Australia are based on the east coast, from where Metallurgical Coal serves a range of customers throughout Asia and the Indian subcontinent, and Europe and South America. Its metallurgical coal operation in Canada, Peace River Coal, mainly serves customers in Europe, Japan and South America. Metallurgical Coal operated six mines, one wholly owned and five in which it has a controlling interest. Five of the mines are located in Queensland�� Bowen Basin: Moranbah North (metallurgical coal), Capcoal (metallurgical and thermal coal), Foxleigh (metallurgical coal), Dawson (metallurgical and thermal coal) and Callide (thermal coal). Drayton mine (thermal coal) is in the Hunter Valley in New South Wales. Moranbah North is an underground longwall mining operation with a mining lease covering 100 square kilometers.

Capcoal operates two longwall underground mines and an open cut mine. Together, they produce around 5.0 MT annually of hard coking coal, pulverised coal injection (PCI) and thermal coal. Capcoal also supplies methane-rich seam gas to Energy Developments Limited�� power station. Foxleigh is an open cut operation with an annual output exceeding 1.4 million tons of PCI coal. During 2012, Dawson, which is an open cut operation, produced 4.6 MT total of coking and thermal coal. During 2012, Capcoal operates two underground mines and an open cut mine. Together, they produced around 6.0 Mt of hard coking, pulverised coal injection (PCI) and thermal coals. During 2012, Foxleigh is an open cut operation which produced 1.9 Mt of high quality PCI coal.

Thermal Coal

Thermal Coal operates in South Africa a! nd and is! a joint partner in Cerrejon, Colombia. In South Africa, Thermal Coal wholly owns and operates nine mines and has a 50% interest in the Mafube colliery and Phola washing plant. During 2012, six of the mines supplied 23 million tons per annum of thermal coal to both export and local markets. New Vaal, New Denmark and Kriel collieries are domestic product operations supplying 29 million tons per annum of thermal coal to Eskom, the state-owned power utility. During 2012, Isibonelo mine produced five million tons per annum of thermal coal for Sasol Synthetic Fuels, the coal to liquids producer, under a 20 year supply contract. Thermal Coal�� South African operations route all export thermal coal through the Richards Bay Coal Terminal (RBCT), in which it has a 24.2% shareholding, to customers throughout the Med-Atlantic and Asia-Pacific regions. Within South Africa, 62% of total sales tons are made to the Eskom power utility.

Copper

The Company has interests in six copper operations in Chile. The wholly owned operations consists of the Mantos Blancos and Mantoverde mines, and it hold a 50.1% interest in Anglo American Sur (AA Sur), which includes the Los Bronces and El Soldado mines and the Chagres smelter. It has a 44% interest in the Collahuasi mine. The mines also produce associated by-products, such as molybdenum and silver. In addition, it has interests in Quellaveco and Michiquillay projects in Peru and a 50% interest in the Pebble project in Alaska.

Nickel

Nickel has three ferronickel operations: Codemin and Barro Alto in Brazil and Loma de Niquel in Venezuela. Within the

business unit�� portfolio there are also two projects, Jacare and Morro Sem Bone, both in Brazil, and exploration projects in Finland, Canada and Australia.

Platinum

The Company�� Platinum business, based in South Africa, is the producer of platinum. Platinum mines, processes and refines the entire range of platinum group metals (PGMs): platin! um, palla! dium, rhodium, ruthenium, iridium and osmium. Base metals such as nickel, copper and cobalt sulphate are secondary products and are contributors to earnings. Platinum�� operations exploit reserve of PGMs, known as the Bushveld Complex, which contains PGMbearing Merensky, UG2 and Platreef ores. During the year ended December 31, 2012, Platinum wholly owns 10 mining operations in production, a tailings re-treatment facility, three smelters, a base metals refinery and a precious metals refinery. Concentrating, smelting and refining of the output are undertaken at Rustenburg Platinum Mines��(RPM) metallurgical facilities. During 2012, Platinum�� 100% owned mining operations consists of the five mines at Rustenburg Section: Khomanani, Bathopele, Siphumelele, Thembelani and Khuseleka; Amandelbult Section�� two mines, Tumela and Dishaba, as well as Mogalakwena and Twickenham mines. Union Mine is 85% held with a black economic empowerment (BEE) partner, the Bakgatla-Ba-Kgafela traditional community, holding the remainder. The Unki mine in Zimbabwe is wholly owned.

Diamonds

The Company�� diamond interests are represented by its 40% holding in De Beers. The other shareholders in De Beers are Central Holdings Ltd, which owns 40%, and the Government of the Republic of Botswana (GRB) with 15%. De Beers is a diamond company producing diamonds from its mines in Botswana, Canada, Namibia and South Africa. As of December 31, 2012, De Beers held a 50% interest in Debswana Diamond Company and in Namdeb Diamond Corporation. In addition, De Beers has a 74% holding in South African based De Beers Mines Limited. De%Beers owns 100% of De%Beers Canada. De%Beers owns 100% of The Diamond Trading Company (DTC). De Beers, through Element Six Technologies, is a supplier of industrial supermaterials. Element Six operates internationally, with 10 manufacturing sites globally and a global sales network.

Advisors' Opinion:
  • [By Ben Kramer-Miller]

    The Pebble Project is an enormous potential mine in Alaska containing mostly copper, and some gold and molybdenum. The project is owned by the Pebble Partnership, of which Northern Dynasty Minerals owns half, while Anglo American (AAUKY.PK) owns the other half.

Best Companies To Own For 2015: Rocket Fuel Inc (FUEL)

Rocket Fuel, Inc., incorporated on March 25, 2008, is a technology company that has developed an Artificial Intelligence and Big Data-driven predictive modeling and automated decision-making platform. Its technology is designed to address the needs of markets in which the volume and speed of information render real-time human analysis infeasible.

The Company�� Artificial Intelligence (AI), system autonomously purchases ad spots, or impressions, one at a time, on these exchanges to create portfolios of impressions designed to optimize the goals of Its advertisers, such as increased sales, heightened brand awareness and decreased cost per customer acquisition. Its solution is designed to optimize both direct-response campaigns focused on generating specific consumer purchases or responses, as well as brand campaigns geared towards lifting brand metrics.

Advisors' Opinion:
  • [By Matt Jarzemsky]

    The start of the year saw a spate of similar offerings, including equity sales by advertising-technology firm Rocket Fuel Inc.(FUEL), data-analysis firm Splunk Inc.(SPLK) and human-resources software maker Workday Inc.

Best Companies To Own For 2015: Tekmira Pharmaceuticals Corp (TKMR)

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing ribonucleic acid (RNA) interference (RNAi) therapeutics and providing its lipid nanoparticle (LNP) delivery technology to pharmaceutical partners. On March 1, 2012, it announced that the Company had secured a license from Alnylam to develop TKMALDH2, an RNAi therapeutic that utilizes Tekmira's LNP for the treatment of Alcohol Dependence (AD). Its lead oncology product candidate, TKM-PLK1, targets PLK1, a protein involved in tumor cell proliferation and a validated oncology target. On February 8, 2012, it announced that Phase I clinical trial for TKM-Ebola had been initiated. The Phase 1 TKM-Ebola clinical trial is a placebo-controlled, single-blind, single-ascending dose study with additional multiple-ascending dose cohorts in healthy human volunteers. In the field of RNAi therapeutics, the Company has licensed its LNP delivery technology to Alnylam Pharmaceuticals, Inc. and Merck & Co., Inc. Advisors' Opinion:
  • [By Lisa Levin]

    Tekmira Pharmaceuticals (NASDAQ: TKMR) shares climbed 34.11% to $13.25. The volume of Tekmira Pharmaceuticals shares traded was 2187% higher than normal. Tekmira signed a development agreement with Monsanto (NYSE: MON) on delivery technology for agricultural applications.

  • [By Markus Aarnio]

    Companies working on chemically synthesized siRNAs include Merck (MRK), through its subsidiary Sirna Therapeutics, Inc., Novartis (NVS), Takeda (TKPHF.PK), Kyowa Hakko Kirin, Marina Biotech, Inc., Arrowhead and its subsidiary, Calando, Quark, Silence Therapeutics plc, Tekmira (TKMR), Sylentis and Dicerna Pharmaceuticals, Inc.

Best Companies To Own For 2015: Sands China Ltd (SCHYF)

Sands China Ltd. (Sands China) is an investment holding company. The Company, along with its subsidiaries, is engaged in the development and operation of integrated resorts in Macao, which contain not only gaming areas, but also meeting space, convention and exhibition halls, retail and dining areas and entertainment venues. The Company operates in five segments: The Venetian Macao, Sands Macao, The Plaza Macao, Sands Cotai Central and ferry and other operations. The Venetian Macao, the Plaza Macao and Other developments derive their revenue primarily from casino, hotel, food and beverage, mall, convention, retail and others sources. Ferry and other operations derive their revenue from the sale of ferry tickets for transportation between Hong Kong and Macau. As of December 31, 2011, its properties included 3,554 hotel rooms and suites, 74 restaurants, 1.2 million square feet of retail, 1.2 million square feet of meeting space, two permanent theaters, a 15,000-seat arena and the casino. Advisors' Opinion:
  • [By MARKETWATCH]

    HONG KONG (MarketWatch) -- Hong Kong stocks sold off early Thursday after the Federal Reserve decided to further taper stimulus, and after a final reading of China's manufacturing PMI contracted. The Hang Seng Index (HK:HSI) sank 1.5% to 21,815.04 in holiday-shortened trading. Tech stocks retreated, as Chinese PC maker Lenovo Group Ltd. (HK:992) (LNVGF) dropped 5.3%, failing to get a lift from news that it plans to acquire the Motorola handset business from Google Inc. (GOOG) for $2.91 billion as Lenovo aims for a bigger presence in the U.S. market. Software developer Kingsoft Corp. (HK:3888) (KSFTF) fell 1.9% and Internet giant Tencent Holdings Ltd. (HK:700) (TCTZF) dropped 1.5%. Casino stocks also declined. Sands China Ltds. (HK:1928) (SCHYF) , the Hong Kong-listed unit of Las Vegas Sands Corp. (LVS) , slipped 0.2%, despite financial results that showed Sands China's net income increased 40% year-on-year to $467 million in the fourth quarter. Melco Crown Entertainment Ltd. (HK:6883) (MPEL) slumped 3.2%, and both Wynn Macau Ltd. (HK:1128) (WYNMF) and MGM China Holdings Ltd. (HK:2282)

Best Companies To Own For 2015: Dover Downs Gaming & Entertainment Inc (DDE)

Dover Downs Gaming & Entertainment, Inc., incorporated in December of 2001, is a premier gaming and entertainment resorts. The Company�� operations consist of: Dover Downs Casino, a 165,000-square foot casino complex featuring table games, including craps, roulette and card games, such as blackjack, Spanish 21, baccarat, 3-card and pai gow poker, the latest in slot machine offerings, multi-player electronic table games, the Crown Royal poker room, a Race & Sports Book operation, the Dover Downs' Fire & Ice Lounge, the Festival Buffet, Doc Magrogan's Oyster House, Frankie's Italian restaurant, as well as several bars, restaurants and four retail outlets; Dover Downs Hotel and Conference Center, a 500 room AAA Four Diamond hotel with a full-service spa/salon, conference, banquet, ballroom and concert hall facilities, and Dover Downs Raceway, a harness racing track with pari-mutuel wagering on live and simulcast horse races. All of its operations are located at its entertainment complex in Dover. Its two wholly owned subsidiaries include Dover Downs, Inc. and Dover Downs Gaming Management Corp.

Dover Downs Casino

The Company's casino had approximately 2,539 slot machines as of December 31, 2011. It is open for business around the clock. During the year ended December 31, 2011, that the facility was visited by approximately 2.6 million patrons. Its slot machines range from penny machines to $100 machines in the Premium Slots area and include games found in the country's major gaming jurisdictions. The Company operates with 40 tables, including blackjack, craps and roulette tables. The Crown Royal poker room has 12 poker tables. It has its Race and Sports Book operation featuring parlay sports wagering on NFL games and pari-mutuel wagering on live and simulcast horse races. Dover Downs, Inc. is authorized to conduct video lottery, sports wagering and table game operations. The Company's Capital Club, a slots players club and tracking system, allows it to identify customers and t! o reward their level of play through various marketing programs.

Dover Downs Hotel

The Company's luxury hotel facility, the Dover Downs Hotel and Conference Center, connects to the Company's casino. The facility includes 500 rooms, including 11 luxury spa suites, a multi-purpose ballroom/concert hall, a fine dining restaurant, swimming pool and a luxurious 6,000 square-foot full-service spa. It offers a range of entertainment options to its patrons, including concerts featuring prominent entertainers, live boxing, gourmet dining, spa facilities, trade shows and conferences. During 2011, hotel occupancy averaged 90%.

Dover Downs Raceway

The Company�� Dover Downs Raceway conducts live harness races from November until April and is simulcast to more than 300 tracks and other off-track betting locations across North America on each of the Company's more than 120 live race dates. The Company's harness racing track is a 5/8-mile track that is located on DVD's property and is on the inside of its one-mile motorsports superspeedway. Additional amenities include the Winners Circle Restaurant overlooking the horse racing track. Within the Company's Race & Sports Book operation is the simulcast parlor where the patrons can wager on harness and thoroughbred races received by satellite into its facility year round from numerous tracks across North America. Television monitors throughout the area provide views of all races simultaneously and the betting windows are connected to a central computer allowing bets to be received on all races from all tracks.

The Company has an agreement with the Delaware Standardbred Owner's Association, Inc. (DSOA) effective September 1, 2010 and continuing through August 31, 2014. DSOA's membership consists of owners, trainers and drivers of harness horses participating in harness race meetings at its facilities and elsewhere in the United States and Canada. Under the DSOA agreement, the Company is required to distrib! ute as pu! rses for races conducted at its facilities a percentage of its retained share of pari-mutuel revenues.

The Company competes with Harrington Raceway and Delaware Park.

Advisors' Opinion:
  • [By Paul Ausick]

    Stocks on the move: Vodafone Group PLC (NASDAQ: VOD) is up 8.1% at $31.80 on reports of discussions with Verizon Communications Inc. (NYSE: VZ) that would result in the sale of Vodafone�� 45% stake in Verizon Wireless to the controlling shareholder. Dover Downs Gaming & Entertainment Inc. (NYSE: DDE) is up 10.8% at $1.54 after Wednesday�� launch of its online casino games that will soon be available to state residents to play for real money.

Best Companies To Own For 2015: EOG Resources Inc.(EOG)

EOG Resources, Inc., together with its subsidiaries, engages in the exploration, development, production, and marketing of natural gas and crude oil primarily in the United States, Canada, the Republic of Trinidad and Tobago, the United Kingdom, and the People's Republic of China. As of December 31, 2010, its total estimated net proved reserves were 1,950 million barrels of oil equivalent (MMBoe), of which 386 million barrels (MMBbl) were crude oil and condensate reserves, and 152 MMBbl were natural gas liquids reserves; and 8,470 billion cubic feet (Bcf) or 1,412 MMBoe were natural gas reserves. The company held approximately 520,000 net acres in the mature oil window of the Eagle Ford Shale Play near San Antonio, Texas. EOG Resources, Inc. was founded in 1985 and is based in Houston, Texas.

Advisors' Opinion:
  • [By Neil Macneale]

    In considering an addition to our portfolio, we looked at EOG Resources (EOG), which is a big ($52B) oil and natural gas producer with decent numbers, but nothing too exciting.

  • [By Robert Rapier]

    EOG Resources (EOG) is the largest producer in the Eagle Ford. That's been one of our big winners; it's up 56% over the past year. We still recommend it, although it is getting up around the buy target that we set for it.

Best Companies To Own For 2015: Janus Capital Group Inc (JNS)

Janus Capital Group Inc., and its subsidiaries (JCG), incorporated on January 23, 1998, provide investment management, administration, distribution and related services to financial advisors, individuals and institutional clients through mutual funds, other pooled investment vehicles, separate accounts and sub advised relationships (collectively referred to as investment products) in both domestic and international markets. JCG provides investment management competencies across a range of disciplines, including fundamental the United States and global equities (growth and value), mathematical equities, fixed income and alternatives through its subsidiaries, Janus Capital Management LLC (Janus), INTECH Investment Management LLC (INTECH) and Perkins Investment Management LLC (Perkins). JCG's investment products are distributed through three primary channels: retail intermediary, institutional and international.

The institutional channel serves the United States corporations, endowments, foundations, Taft-Hartley funds and public fund clients and focuses on distribution direct to the plan sponsor and through consultants. As of December 31, 2012, assets in the institutional channel totaled 24% of total Company assets under management. The international channel primarily serves professional retail and institutional investors outside of the United States, including central and local government pension plans, corporate pension plans, multi-managers, insurance companies and private banks. International products are offered through separate accounts, sub advisory relationships and Janus Capital Funds Plc, a mutual fund trust. As of December 31, 2012, assets in the international channel totaled 11% of total Company assets under management. JCG operates international offices in London, Paris, Milan, Munich, Frankfurt, The Hague, Dubai, Zurich, Singapore, Hong Kong, Tokyo, Melbourne and Taipei. The retail intermediary channel serves financial advisors, third-party intermediaries and retirement platf! orms in the United States. In addition, this channel serves existing individual investors who invest in JCG products through a mutual fund supermarket or directly with JCG. As of December 31, 2012, assets in the retail intermediary channel totaled 65% of total Company assets under management.

Janus

Janus manages primarily growth equity portfolios. As of December 31, 2012, Janus managed 63% of total Company assets under management. The Janus Overseas Fund is included in the assets managed by Janus and represented approximately 6% during the year ended December 31, 2012.

INTECH

INTECH has managed institutional portfolios. INTECH's investment process is based on a mathematical theorem that seeks to add value for clients by capitalizing on the volatility in stock price movements. As of December 31, 2012, INTECH managed 26% of total Company assets under management.

Perkins

Perkins has managed value-disciplined investment products. With its fundamental research and careful consideration for downside risk, Perkins has established itself as a value manager. Perkins offers value equity investment products across a range of the United States asset classes and global equity. As of December 31, 2012, Perkins managed 11% of total Company assets under management.

Advisors' Opinion:
  • [By Dan Caplinger]

    Who wants in on the action?
    All that said, plenty of mutual fund companies have seen the writing on the wall and are eager to come to market with active ETFs. Mutual fund giants Fidelity, Franklin Templeton (NYSE: BEN  ) , Janus Capital (NYSE: JNS  ) , and Legg Mason (NYSE: LM  ) are just some of the companies looking to follow in PIMCO's footsteps with active ETFs. Each of these companies owes a huge portion of its profits to management fees on the billions in assets that it holds, and each recognizes the need to defend its turf by reaching into the ETF space. For Legg Mason and Franklin Templeton, which already offer closed-end mutual funds that trade on exchanges, moving to ETFs is an even shorter step.

  • [By Rich Bieglmeier]

    As is it is every week, iStock found a company within the list of transactions worthy of further discussion. Today, we find some interest with Janus Capital Group, Inc. (JNS).

  • [By Matt Jarzemsky]

    “Valuations for many of these companies seem just as stretch as Internet stocks were back then,” asset management firm Janus Capital(JNS) writes in its latest monthly equities update. Some Janus funds rode high-flying technology and communications stocks to big gains during the 1990s, but saw those bets sour as the tech bubble burst.

No comments:

Post a Comment